Eris Lifesciences Limited — Financials & Forensics
Sector: Healthcare · NSE: ERIS · BSE: 540596 · ISIN: INE406M01024
07 Sep 2026
Add ERIS to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹1,347 Cr | ₹1,685 Cr | ₹2,009 Cr | ₹2,894 Cr | ₹3,129 Cr |
| EBITDA | ₹485 Cr | ₹537 Cr | ₹675 Cr | ₹1,017 Cr | ₹1,120 Cr |
| EBITDA margin | 36.0% | 31.9% | 33.6% | 35.1% | 35.8% |
| Profit after tax | ₹406 Cr | ₹374 Cr | ₹397 Cr | ₹352 Cr | ₹620 Cr |
Deeper analysis
Recent filings by Eris Lifesciences Limited
-
As Attached
29 Jul 2026 · General Update
-
Investor Presentation
29 Jul 2026 · Financial Results
-
as attached
29 Jul 2026 · Financial Results
Never miss a filing again
About Eris Lifesciences Limited on Indian Stock Alerts
Indian Stock Alerts tracks Eris Lifesciences Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.